Daniel Auclair/X
Jun 16, 2025, 17:37
Daniel Auclair Highlights GMMG-CONCEPT Study Presentation by Lisa Leypoldt at EHA 2025
Daniel Auclair, President at Hematocure, LLC, posted on X:
“Dr. Lisa Leypoldt (congrats again on Young Investigator Award!) presenting GMMG-CONCEPT study, the largest prospective trial so far of purely HR NDMM, at EHA2025.
Isa-KRd induction/consolidation and Isa-KR maint. produced high rates MRDneg and was well tolerated.”
More posts featuring EHA 2025 on Hemostasis Today.
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care